Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-25-025778
Filing Date
2025-12-02
Accepted
2025-12-02 16:56:05
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 362844
2 EX-4.24 ex4-24.htm EX-4.24 117018
3 EX-5 ex5.htm EX-5 27821
4 EX-23.2 ex23-2.htm EX-23.2 4183
5 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 79989
6 GRAPHIC forms-3_001.jpg GRAPHIC 4058
7 GRAPHIC ex5_001.jpg GRAPHIC 4122
  Complete submission text file 0001493152-25-025778.txt   741928

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 10356
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291892 | Film No.: 251543897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)